Viewing StudyNCT00179738



Ignite Creation Date: 2024-05-05 @ 11:54 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00179738
Status: TERMINATED
Last Update Posted: 2005-11-23
First Post: 2005-09-10

Brief Title: A Multicenter Single-Arm Open-Label Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide Revlimid CC-5013 in Subjects With Androgen Independent Prostate Cancer
Sponsor: Celgene Corporation
Organization: Celgene

Organization Data

Organization: Celgene
Class: INDUSTRY
Study ID: CC-5013-PC-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Celgene Corporation
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Prologue Research International INDUSTRY